If you want to receive notifications of upcoming IPOs, you need to simply sign up or sign in with social networks.
Can you determine which companies are good and which ones - the trash?
Free Pro-version
IPO Filter
IPO today
Upcoming IPO
Austin Gold (AUST)
Intensity Therapeutics (INTS)
Genenta Science (GNTA)
Chicago Atlantic Real Estate Finance, Inc. (REFT)
Chicago Atlantic Real Estate Finance (REFI)
Nu Holdings Ltd. (NU)
Hashicorp, Inc. (HCP)
Fresh Vine Wine, Inc. (VINE)
Priced IPO
AeroClean Technologies (AERC)
Finwise Bancorp (FINW)
Kindercare Learning Companies, Inc. (KLC)
Snow Lake Resources (LITM)
Sweetgreen, Inc. (SG)
Usertesting, Inc. (USER)
Braze, Inc. (BRZE)
Sono Group N.v. (SEV)
Iris Energy Limited (IREN)
Mynaric Ag (MYNA)
Journey Medical Corporation? (DERM)
Tivic Health Systems (TIVC)
Blackboxstocks (BLBX)
Kidpik (PIK)
Vaxxinity, Inc. (VAXX)
Lulus Fashion Lounge Holdings, Inc. (LVLU)
Weave Communications, Inc. (WEAV)
Backblaze, Inc. (BLZE)
HeartBeam, Inc. (BEAT)
Rivian Automotive, Inc. (RIVN)
More companies

Minerva Surgical, Inc (UTRS)

Sector - Healthcare

Price chart

Return from IPO

Company News

IPO Profile

About company

They are a commercial-stage medical technology company focused on developing, manufacturing, and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women. They have established a broad product line of commercially available, minimally invasive alternatives to hysterectomy, which are designed to address the most common causes of abnormal uterine bleeding (AUB) in most uterine anatomies. AUB is caused by a variety of factors and is characterized by menstrual blood loss in excess of 80 milliliters (ml) per menstrual cycle, which is two to three times the average blood loss during a normal menstrual cycle. Their solutions can be used in a variety of medical treatment settings and aim to address the drawbacks associated with alternative treatment methods and to preserve the uterus by avoiding unnecessary hysterectomies. They offer a broad suite of products for the treatment of structural and non-structural causes of AUB in most uterine anatomies. Their devices are utilized by obstetrician-gynecologists (OB/GYNs) across a variety of medical treatment settings, including hospitals, ambulatory surgical centers (ASCs), and physician offices. They market and sell their products through a direct sales force in the United States. Their target customer base includes approximately 19,000 OB/GYNs practicing in hospital, ASCs, and physician offices.
Surgical & Medical Instruments & Apparatus
Employees Founded
139 2008


Address: 4255 Burton Dr. Santa Clara, Ca 95054

Telephone: (855) 646-7874

Web page:

IPO information

First Trade Date 10/22/2021
Status Priced
Exchange NASDAQ
Lockup Period Expiration .Pro
Quiet Period Expiration .Pro
Old Price Range
Share prices ($)

Shares & Volumes

Shares Initial (MM) 6.3
Shares Revised (MM) 6.25
Expected offer amount (MM) $100
Realized offer amount(MM) $75

Financial Data (last reporting year)

Market Cap (MM) $457.09
Revenues (MM) $51.78
Net Income (Loss) (MM) $-42.74


What do you think will happen with the UTRS share price after the next 3-6 months? 🔥 (+ 10% or more, flat (+ -10%), -10% or less)

Number of votes: img
The lead left underwriter: JP Morgan

IPOs led by the firm .Pro
Profitability of conducted IPOs  ?  .Pro
1st day change  ?  .Pro
Change for the first 3 months  ?  .Pro
JP Morgan/ Piper Sandler/ UBS Investment Bank/ SVB Leerink

Sector: Healthcare

Tweets about $UTRS

Tweets volume:

RT volume:


Google Trends Stats